Exploring the link between fatty liver disease and breast cancer
The Relationship Between Fatty Liver and Breast Cancer
This study is trying to see if having non-alcoholic fatty liver disease affects the chances of developing or worsening breast cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06402084 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between non-alcoholic fatty liver disease (NAFLD) and breast cancer. It aims to understand how NAFLD, which affects a significant portion of the population, may influence the development and progression of breast cancer. The study will utilize abdominal ultrasound to assess liver conditions in patients diagnosed with breast cancer. By examining the clinicopathological results, the research seeks to uncover potential metabolic links between these two conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 65 who have been diagnosed with breast cancer and have varying degrees of performance status.
Not a fit: Patients with severe comorbidities or those who have declined cancer treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how managing fatty liver disease may improve outcomes for breast cancer patients.
How similar studies have performed: While the relationship between fatty liver disease and various cancers has been suggested, this specific investigation is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 65 years old)-Age (18-1 performance (PS0;full active,noPerformance status \< or equal to 2 Patients with-2PS1;strenuous physical activity restricted,fully ambulatory and able to ----restriction.care but unable to carry out any work -PS2;capable of all self-------carry out light work.activities up and about \>50% of woking hours) Exclusion Criteria: * Patients who had double malignancy.-1 Patients who had severe comorbidities -2 heart failure…..etc,)(pulmonary failure,Renal failure, Those who declined cancer treatment before completing 85% of the planned dosage -3 hose who are lost during the follow up period.tor
Where this trial is running
Sohag
- Sohag university Hospital — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: samar S Abd El-Rahman, resident
- Email: samar.saad@med.sohag.edu.eg
- Phone: 01157685509
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.